Institute for Medical Education and Research, Madelyn Trupkin Herzfeld, IMER, imer, imier, Miami, Florida, Nursing CE's, Nursing contact hours, nursing education, continuing education, medical research and education, Oncology, Postgraduate credit, oncology nurses, nurses, symposia, symposium, online educational credit, Breast Cancer, Cancer, cancer, breast cancer, colorectal cancer, Colorectal Cancer, Targeting EGFR, EGFR Inhibitors, egfr inhibitors, head and neck cancer, Anti-VEGF, VEGF Inhibitors, vegf inhibitors, lung cancer, head cancer, CINV, cinv, Chemotherapy Induced Nausea & Vomiting, chemotherapy, nausea, vomiting, mucositis, cancer pain, chronic pain  
Is Your Patient at Risk? Nursing Strategies for the Management of Tumor Lysis Syndrome and Venous Thrombolism
   
  CE REGIONAL MEETINGS FOR ONCOLOGY NURSES

IMER Regional Meeting

Is Your Patient at Risk? Nursing Strategies for the Management of Tumor Lysis Syndrome and Venous Thromboembolism

Sponsored by:

IMER

Target Audience

This activity has been designed to meet the educational needs of oncology nurses and related healthcare professionals working with the patient population in both the acute and ambulatory care settings.

Purpose

To educate nurses regarding the prophylaxis and treatment of tumor lysis syndrome (TLS) and venous thromboembolism (VTE).

Program Overview

Patients with cancer are at risk for numerous disease- and treatment-related complications that, if not addressed appropriately, can be life threatening, including TLS and VTE. Prophylaxis and management of such complications are primary responsibilities of oncology nurses; however, clinical presentation may vary between the acute care and ambulatory settings. To support oncology nurse attendees’ efforts to provide individualized patient evaluation and treatment planning, this presentation will provide case-based scenarios outlining assessment, prophylaxis, and management strategies for patients with TLS and VTE specific to inpatient and outpatient settings. Following case studies, each table of participants will collaborate to address questions relating to the management of the case, before sharing their analysis with the remaining program attendees. Faculty will provide expert feedback to these interactive sessions. Participants can elect to receive an e-mail series describing follow-up case scenarios for patients presented during the live meeting, with questions related to appropriate clinical management. The case study question results, along with faculty commentary, will be distributed to each participant.

Learning Objectives

TLS

  • Identify risk factors for TLS in patients with cancer and describe new predictive models
  • Describe the benefits of prophylactic treatment for patients at high risk for TLS
  • Describe the signs and symptoms of the four metabolic complications of TLS
  • Describe appropriate medical and nursing management of patients who have been diagnosed with TLS
  • Identify clinical research related to prophylaxis and treatment of hyperuricemia secondary to TLS

VTE

  • Identify risk factors for VTE in patients with cancer
  • Identify current guidelines for prevention and management of VTE
  • Describe optimal prevention and treatment options for VTE
  • Review clinical studies related to prophylaxis and treatment of VTE with low-molecular-weight heparin
  • Describe appropriate acute and long-term anticoagulation strategies for the treatment of VTE

 

Chairperson

Christopher R. Friese, PhD, AOCN®
University of Michigan School of Nursing and Comprehensive Cancer Center

There is no fee for this educational activity.

This activity is supported by an independent educational grant from sanofi-aventis U.S.
 

Additional CE Meetings on This Topic:

Click on the column headers to sort and on a city for more details.
{date} {city} {speaker}

{icon}
{location}

 

More meetings to be added in the near future. Check for updates.

 

Program Agenda

Program Overview 5 minutes
Tumor Lysis Syndrome Overview 20 minutes
Case Scenario 10 minutes
Venous Thromboembolism Overview 20 minutes
Case Scenario 10 minutes
Questions & Answers 15 minutes

 

Disclosure of Conflicts of Interest

The Institute for Medical Education & Research (IMER) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by IMER for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Accreditation Statements

This educational activity for up to 1.3 contact hours will be provided by the Institute for Medical Education & Research (IMER). IMER is an approved provider of continuing education by the Georgia Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

IMER is approved by the California Board of Registered Nursing, Provider Number 14763 for 1.6 contact hours.

Application pending approval with the American Academy of Nurse Practitioners (including pharmacology hours).

 

 

  
   

© Copyright 2003 – 2008 Institute For Medical Education & Research, Inc. All Rights Reserved.